I have been doing this pretty much since I came on board. The pros and funds are in general no better informed about biotech than the average retail investor. When I talk to them I explain what we are doing and our future plans (no selective disclosures) in a way that brings all our news flow into a coherent picture that they can understand. It is very satisfying when you go into a meeting with these pros and they are cynical (they get pitched dozens of investments every week) and they leave excited about RAC and head to their screens to buy.
Ann: Race significantly strengthens Clinical Advisory Board, page-29
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $192.7M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.14 | $338.0K | 283.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2214 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 1000 | 1 |
View Market Depth
| Last trade - 13.37pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.16 |
Change
-0.070 ( 5.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.23 | $1.23 | $1.14 | 33724 | ||
| Last updated 14.38pm 03/05/2024 ? | |||||
| RAC (ASX) Chart |